Why the study?
Does patient self-management of warfarin therapy based on fingerstick prothrombin times allow for safe and effective dose regulation in patients on long-term oral anticoagulation?
Population
16 patients on long-term oral anticoagulation (warfarin)
Design
Case_series
Follow-up
mean 43 weeks (range, 8 to 92 weeks)
Authors
Loading...
Patient self-management of warfarin appears feasible without complications; leaves open whether randomized trials confirm safety versus standard monitoring.
Does patient self-management of warfarin therapy based on fingerstick prothrombin times allow for safe and effective dose regulation in patients on long-term oral anticoagulation?
Patient self-management of warfarin therapy using fingerstick prothrombin times is feasible and safe, offering potential for improved care at reduced cost.
J. Ansell (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: